(Q38453405)

3 September 2017

title

The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study (English)

1 reference

3 September 2017

1 reference

4

Manfred Uhr

1 reference

3 September 2017

6

Florian Holsboer

1 reference

3 September 2017

Barbara Breitenstein

1

1 reference

3 September 2017

Sandra Scheuer

2

1 reference

3 September 2017

Hildegard Pfister

3

1 reference

3 September 2017

Susanne Lucae

5

1 reference

3 September 2017

Marcus Ising

7

1 reference

3 September 2017

Tanja M Brückl

8

1 reference

3 September 2017

publication date

23 July 2013

1 reference

3 September 2017

1 reference

3 September 2017

volume

19

1 reference

3 September 2017

issue

2

1 reference

3 September 2017

page(s)

165-175

1 reference

Perspectives of P-glycoprotein modulating agents in oncology and neurodegenerative diseases: pharmaceutical, biological, and diagnostic potentials

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

CYP2C19 variation and citalopram response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Risperidone and paliperidone inhibit p-glycoprotein activity in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Utility and adoption of CYP2D6 and CYP2C19 genotyping and its translation into psychiatric clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-Glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Pharmacogenomics of antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Sertraline and its metabolite desmethylsertraline, but not bupropion or its three major metabolites, have high affinity for P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

abcb1ab P-glycoprotein is involved in the uptake of citalopram and trimipramine into the brain of mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Blood-brain barrier penetration and pharmacokinetics of amitriptyline and its metabolites in p-glycoprotein (abcb1ab) knock-out mice and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

A note on exact tests of Hardy-Weinberg equilibrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

How can we realize the promise of personalized antidepressant medicines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Genome-wide pharmacogenetics of antidepressant response in the GENDEP project

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Antidepressants and ABCB1 Gene C3435T Functional Polymorphism: A Naturalistic Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

MDR1 gene polymorphism: therapeutic response to paroxetine among patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Pharmacokinetic genes do not influence response or tolerance to citalopram in the STAR*D sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

HTR2A gene variation is involved in antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

Clinical and genetic correlates of suicidal ideation during antidepressant treatment in a depressed outpatient sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

7 January 2021

Rapid weight gain during mirtazapine treatment

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

7 January 2021

ABCB1 (P-glycoprotein/MDR1) gene G2677T/a sequence variation (polymorphism): lack of association with side effects and therapeutic response in depressed inpatients treated with amitriptyline

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

7 January 2021

Dose-dependent effects of the 3435 C>T genotype of ABCB1 gene on the steady-state plasma concentration of fluvoxamine in psychiatric patients

1 reference

https://api.crossref.org/works/10.1017%2FS1092852913000436

7 January 2021

10.1017/S1092852913000436

Identifiers

DOI

1 reference

3 September 2017

1 reference